Back

Time to act: Stabilising the vulnerable plaque with PCSK9i.

30 August 2021 (19:01 - 19:11)
Organised by:
Congress Presentation Part of: LDL-C management in ACS: Time to Act Interventional Cardiology Open Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Stephen Nicholls

Monash University, Melbourne (Australia)

3 More presentations in this session

Presentation thumbnail
Introduction.
Professor D. Connolly (Birmingham, GB)
Presentation thumbnail
Time to act: When should ACS patients reach their LDL-C goal?
Professor G. Montalescot (Paris, FR)
Presentation thumbnail
Discussion & close.
Professor D. Connolly (Birmingham, GB)

Access the full session

Session thumbnail
LDL-C management in ACS: Time to Act
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

30 August 2021 19:01 CET
You may be interested in
thumbnail
Congress Session
PCSK9 inhibitors for acute coronary syndromes: the era of early implementation
30 August 2024
thumbnail
Congress Presentation
Carotid plaques stabilization and regression with evolocumab
1 September 2025
thumbnail
Congress Presentation
Effect of PCSK9 inhibitors on coronary plaque: a meta-analysis and trial sequential analysis
1 September 2025
thumbnail
Congress Presentation
Early PCSK9 inhibitor subscription during episode of acute myocardial infarction (EPISODE-AMI) study
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources